E For L Aim PCL (BKK:EFORL) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:EFORL E For L Aim PCL BKK:EFORL
24 GF Score
Price ฿0.11
GF Value ฿0.14
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is E For L Aim PCL Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

E For L Aim PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿164 Mil. E For L Aim PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿108 Mil. E For L Aim PCL's annualized EBITDA for the quarter that ended in Jun. 2026 was ฿111 Mil. E For L Aim PCL's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 2.46.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for E For L Aim PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:EFORL' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -14.59   Med: -0.06   Max: 5.14
Current: 2.31

During the past 13 years, the highest Debt-to-EBITDA Ratio of E For L Aim PCL was 5.14. The lowest was -14.59. And the median was -0.06.

BKK:EFORL's Debt-to-EBITDA is ranked worse than
51.61% of 93 companies
in the Medical Distribution industry
Industry Median: 2.29 vs BKK:EFORL: 2.31

E For L Aim PCL  (BKK:EFORL) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


E For L Aim PCL Debt-to-EBITDA Related Terms


E For L Aim PCL Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for E For L Aim PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

E For L Aim PCL Debt-to-EBITDA Chart

E For L Aim PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

E For L Aim PCL Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BKK:EFORL vs MCK, COR, CAH: Debt-to-EBITDA Comparison

For the Medical Distribution subindustry, E For L Aim PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


E For L Aim PCL Debt-to-EBITDA vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where E For L Aim PCL's Debt-to-EBITDA falls into.


BKK:EFORL
24GF Score
E For L Aim PCL BKK:EFORL
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

E For L Aim PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

E For L Aim PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(162.23 + 138.496) / 119.46
=2.52

E For L Aim PCL's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(164.372 + 107.627) / 110.744
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is E For L Aim PCL (BKK:EFORL) Overvalued in 2026?

Based on GuruFocus' analysis, E For L Aim PCL stock appears to be undervalued. The current stock price of ฿0.11 is trading 21.4% below its estimated GF Value™ of ฿0.14. GuruFocus considers E For L Aim PCL to be Modestly Undervalued.

Key valuation signals for BKK:EFORL:

  • Debt-to-EBITDA:
  • GF Value™: ฿0.14 vs. price of ฿0.11 (21.4% below fair value)
  • GF Score™: 24/100 with 7 warning signs

No single metric tells the full story. See the BKK:EFORL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


E For L Aim PCL Business Description

Other Exchanges EFORL-R:Thailand
Address 432, Rajavithi road, Bangyeekhan Sub District, Bangplad District, Bangkok, THA, 10700
E For L Aim PCL is engaged in the distribution of medical devices and equipment. The company and subsidiary have distributor agreements for medical devices and equipment with foreign companies. Its products include Patient Monitor System, Central Monitors System, Defibrillator, Automated External Defibrillator (AED), Electrocardiographs, Electroencephalogram (EEG), PSG System (Sleep Labs), and Accessories and Consumables. The group is principally engaged in one operating segment which is the distribution of medical device and equipment and providing service of medical equipment. Their operations are carried out in Thailand.
24GF Score

Get the complete analysis for BKK:EFORL

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.11
Price
฿0.14
GF Value